secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2022-02-08T23:59:59+00:00
Accession:  0001681622-22-000009
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q1 FY2022 revenue $199M below expectations; non-GAAP EPS $0.25; guides Q2 revenue $190-220M
--------------------------------------------------------------------------------

- Revenue $199M (+12% YoY, -12% sequential); GAAP EPS $0.03; non-GAAP EPS $0.25.
- Medical segment revenue +12% YoY; Industrial +14% YoY; supply chain constraints limited order fulfillment.
- Cash and equivalents $158M (+$13M QoQ); operating cash flow $11M.
- Q2 FY2022 guidance: revenue $190-220M; non-GAAP EPS $0.15-$0.40.
- Gross margin: GAAP 33%, non-GAAP 34%; operating expense control drove profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162222000009/0001681622-22-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162222000009/vrex-20220208.htm
  HTML page:      https://secwatch.observer/filing/0001681622-22-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer